Xeljanz: How It Works and Who It’s Really For

Описание: Discover how Xeljanz (tofacitinib) works, who it’s for, and what to expect—from a board-certified rheumatologist.
In this video, Dr. Rezaian, specialist in arthritis and rheumatology, breaks down everything you need to know about Xeljanz, a JAK inhibitor used to treat autoimmune conditions like rheumatoid arthritis, ulcerative colitis, psoriatic arthritis, and more.

You’ll learn:
• What Xeljanz is and how it works (JAK-STAT pathway explained simply)
• FDA-approved and off-label uses
• Pros, cons, and common side effects
• What labs and vaccines are needed before starting treatment
• How it compares to other autoimmune medications
• Who should and shouldn’t take it
• Typical dosing and how fast it starts working

Whether you’re a patient exploring treatment options or a medical learner curious about JAK inhibitors, this is your complete Xeljanz overview.

Timestamps:
00:00 – Intro
00:30 – Medical disclaimer
01:05 – What is Xeljanz?
02:15 – Conditions it treats
03:10 – How it works
04:00 – Pros and cons
05:00 – Safety labs and monitoring
06:10 – Who should avoid it
07:00 – Dosing and results
08:00 – Final thoughts

Subscribe for more expert insights on autoimmune care and rheumatology treatments.
Have questions about JAK inhibitors? Drop them in the comments!

#Xeljanz #Tofacitinib #RheumatoidArthritis #AutoimmuneDisease #JAKInhibitors #UlcerativeColitis #PsoriaticArthritis #DrRezaian #Rheumatology